Dengue variants

Reading File
Finding Sources
Searching PubMed

dengue serotypes

Searching the Web

WHO dengue virus four serotypes DENV-1 DENV-2 DENV-3 DENV-4

Dengue virus has 4 main serotypes (variants):
  1. DENV-1
  2. DENV-2
  3. DENV-3
  4. DENV-4
They are closely related viruses spread mainly by Aedes mosquitoes. Each serotype also contains multiple genetic genotypes/lineages.
  • Infection with one serotype usually gives long-term immunity to that same serotype.
  • Protection against the other three is temporary.
  • A later infection with a different serotype can carry a higher risk of severe dengue, partly because cross-reactive antibodies may enhance viral entry into cells.
  • Any of the four serotypes can cause severe disease. Some settings have linked DENV-2 more often with severe outcomes, but severity depends on host factors, previous infection, age, comorbidities, and the particular viral lineage.
The WHO dengue overview confirms the four serotypes and the increased risk with a different-serotype reinfection. Textbook sources similarly describe durable type-specific immunity with only short-lived cross-protection: Robbins, Cotran & Kumar Pathologic Basis of Disease, Dengue section.

How relevant is Detection of Dengue by PCR method

Reading File
Finding Sources
Searching PubMed

dengue PCR diagnosis

Searching the Web

CDC dengue PCR NAAT testing first 7 days illness guidance

Detection of dengue by RT-PCR is highly relevant, especially during the early acute phase of illness.
  • It detects dengue viral RNA directly, confirming an active infection.
  • It is most useful from day 0 to day 7 after symptoms begin, when viraemia is highest.
  • A positive result is highly specific and can often identify the infecting serotype: DENV-1, DENV-2, DENV-3, or DENV-4.
  • Serotype identification is useful for outbreak surveillance, tracking circulating variants/lineages, and public-health investigations.
  • It can help distinguish dengue from other similar illnesses such as chikungunya or Zika, depending on the assay used.
Limitation: A negative PCR does not rule out dengue, particularly if the sample is collected after day 7, when virus levels may have declined. At that point, dengue IgM serology is more useful. In clinical practice, PCR or NS1 antigen testing is often combined with IgM testing for better diagnostic coverage.
The CDC testing guidance recommends molecular testing during the first 0-7 days of symptoms; after this, antibody testing becomes increasingly important. Textbook references also describe RT-PCR as a preferred virologic confirmation method in acute dengue: Park's Textbook of Preventive and Social Medicine, Laboratory Diagnosis section.
A recent systematic review and meta-analysis also assessed RT-PCR alongside NS1 and IgM assays for acute dengue diagnosis (Pillay et al., 2025).

How does dengue PCR compare with NS1 antigen and IgM testing?

Reading File
Finding Sources
Searching PubMed

dengue RT-PCR NS1 IgM diagnosis

Searching the Web

CDC clinical testing guidance dengue molecular NS1 antigen IgM timing 0-7 days

FeatureRT-PCR / NAATNS1 antigenDengue IgM antibody
DetectsViral RNAViral NS1 proteinPatient immune response
Best timingDays 0-7 of illnessDays 0-7 of illnessFrom about day 3-5 onward, most reliable after day 7
Main strengthDirect, highly specific confirmation; may identify serotypeFaster and often simpler than PCR; useful earlyUseful when virus/NS1 have declined, so it covers later presentation
Main limitationSensitivity falls after the first week; requires molecular laboratory facilitiesSensitivity varies by assay and may be lower in secondary dengue infectionCan cross-react with related flaviviruses and may persist for weeks to months, so it does not always prove a new acute infection
Serotype resultYes, with type-specific assaysNoNo
Typical roleBest virologic confirmation in early disease and for surveillancePractical early screening/diagnosis when PCR is unavailableSupports diagnosis later in illness or after negative early tests

Practical interpretation by illness day

  • Days 0-3: RT-PCR and NS1 are most useful. Add IgM if available, but it may still be negative.
  • Days 4-7: Use RT-PCR or NS1 plus IgM. Combining a direct viral test with IgM improves coverage.
  • After day 7: IgM is usually the key test. PCR and NS1 may still occasionally be positive but are less sensitive.
  • Positive RT-PCR: confirms acute dengue infection.
  • Positive NS1: supports acute dengue, but laboratory method and assay performance matter.
  • Isolated positive IgM: indicates recent dengue-compatible infection but may need interpretation with travel/exposure history and, where relevant, confirmatory testing because of flavivirus cross-reactivity.
The CDC diagnostic guidance states that both molecular tests and NS1 are most useful in the first 0-7 days, while IgM becomes detectable after about day 3. The CDC Yellow Book notes that IgM can remain detectable for up to about 90 days in some patients.
In short: PCR is the best early confirmatory and serotyping test; NS1 is an accessible early alternative; IgM is essential for later presentations. A 2025 systematic review compared RT-PCR, NS1 ELISA, and IgM ELISA directly (Pillay et al.).
This is a shared conversation. Sign in to Orris to start your own chat.